Search Results

Site Search

QuantiFERON-TB Gold Plus - Insights

In this month’s “Hot Topic,” Elitza Theel, Ph.D. will discuss a new interferon-gamma release assay that can assist in the detection of individuals that are infected with tuberculosis.

MayoComplete next-generation sequencing: Transforming comprehensive cancer care - Insights

Offering increased sensitivity and improved accuracy, MayoComplete next-generation testing ensures health care providers understand the distinctive genetic features of their patients’ cancer to make informed decisions to guide their care.

Autoimmune Movement Disorders - Mayo Clinic Laboratories

Our phenotype specific testing for autoimmune movement disorders contain clinically relevant antibodies providing accurate answers for treatment guidance.

MASS-FIX - Insights

Learn more about matrix-assisted laser desorption/ionization-time of flight mass spectrometry and the identification of plasma cell disorders.

Rare patient case helps inform and validate GABA-A-R antibody encephalitis testing: JoAnne Michael - Insights

JoAnne Michael’s symptoms started with dizziness and forgetfulness before down spiraling into severe confusion, crying jags, and brain seizures. ER doctors at her local hospital initially thought she was on drugs. JoAnne, terrified,...

Neurogenetic Testing - Mayo Clinic Laboratories

We offer comprehensive neurogenetic testing, backed by a multidisciplinary team of clinical neurology experts, laboratory scientists, and genetic counselors, to provide the highest standard for mutation detection and depth of coverage.

Every test tube connects to a patient: Quality control of specimens in the pre-analytic phase - Insights

Each day, some 40 to 45 thousand specimens are shipped to Mayo Clinic Laboratories in Rochester, Minnesota, from hospitals and other health care organizations around the world. And for every sample, there’s a patient to whom it belongs,...

Progressive alliance advances science through patient-powered research - Insights

Tying together the expertise and curiosity of Mayo Clinic autoimmune neurology researchers with eager patients who have rare disease and are looking for answers, the innovative collaboration benefits both patients affected by MOGAD and...

IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) - Insights

In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53...

Cutting-Edge Bacterial Testing for the Diagnosis of Patient Infections and Outbreak Mitigation - Insights

Mayo Clinic Laboratories is one of the few laboratories in the country to offer two special sequencing-based tests for bacteria in its catalog. The first test is designed to help protect patients by investigating potential outbreaks of a...